Ranibizumab News and Research

RSS
IQWiG examines added benefit of aflibercept in macular oedema after branch retinal vein occlusion

IQWiG examines added benefit of aflibercept in macular oedema after branch retinal vein occlusion

Study could offer new way to treat, prevent diabetes-associated blindness

Study could offer new way to treat, prevent diabetes-associated blindness

Anti-VEGF therapy benefits in wet AMD not sustained

Anti-VEGF therapy benefits in wet AMD not sustained

No added benefit with pazopanib over ranibizumab for neovascular AMD

No added benefit with pazopanib over ranibizumab for neovascular AMD

Similar diabetic macular oedema outcomes with deferred vs prompt laser therapy

Similar diabetic macular oedema outcomes with deferred vs prompt laser therapy

Risk factors predict geographic atrophy after anti-VEGF treatment of RAP

Risk factors predict geographic atrophy after anti-VEGF treatment of RAP

New edition of WHO Essential Medicines List includes new treatments for hepatitis C, cancers and multi-drug TB

New edition of WHO Essential Medicines List includes new treatments for hepatitis C, cancers and multi-drug TB

WHO moves to improve access to lifesaving medicines for hepatitis C, Drug-resistant TB and cancers

WHO moves to improve access to lifesaving medicines for hepatitis C, Drug-resistant TB and cancers

Clinical study comparing effectiveness of three standard treatments for DME published in NEJM

Clinical study comparing effectiveness of three standard treatments for DME published in NEJM

Ranibizumab drug reverses diabetes-related blindness

Ranibizumab drug reverses diabetes-related blindness

Retinal venular calibre predicts ranibizumab vision improvement

Retinal venular calibre predicts ranibizumab vision improvement

Meta-analysis gives intravitreal ranibizumab vascular adverse risk profile

Meta-analysis gives intravitreal ranibizumab vascular adverse risk profile

VEGF inhibition does not regulate collateral vessels in retinal vein occlusion

VEGF inhibition does not regulate collateral vessels in retinal vein occlusion

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Study: Lower-income students in China have better vision compared to middle-class counterparts

Study: Lower-income students in China have better vision compared to middle-class counterparts

Added benefit of aflibercept not proven in patients with diabetic macular oedema

Added benefit of aflibercept not proven in patients with diabetic macular oedema

Apellis Pharmaceuticals completes $33M private placement of Series C Preferred Stock

Apellis Pharmaceuticals completes $33M private placement of Series C Preferred Stock

Success for nurse practitioner-delivered intravitreal injection service for wAMD

Success for nurse practitioner-delivered intravitreal injection service for wAMD

DEX implant improves visual acuity in patients with diabetic macular oedema

DEX implant improves visual acuity in patients with diabetic macular oedema

Second treated eyes with nAMD functionally more important than first eyes

Second treated eyes with nAMD functionally more important than first eyes